Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

Bimatoprost may help with hair loss.

The document concludes that adding hair restoration services can boost a cosmetic practice's business.

Mesotherapy might help with hair and scalp problems.

Finasteride can cause side effects like liver issues and hormonal changes.

Grow a hair-restoration business by improving marketing, offering diverse services, and enhancing customer service.

Learn how to create and run a global hair-restoration business.

Handling problems in hair restoration involves careful planning, technique, and aftercare.

Switching from a big company to a one-person hair-restoration surgery business is possible.

Consultants guide and advise on hair restoration procedures.

Telogen effluvium is a condition that causes temporary hair loss.

Various surgical methods for hair restoration, like scalp reconstruction and tissue expansion, have been developed, but follicular unit transplant remains the most common procedure for correcting pattern baldness.

Telogen effluvium is a condition that causes temporary hair loss due to stress or shock to the body.

Hair loss can be caused by hormones and genetics.

Hair loss is mainly due to genes and hormones, and can be treated with minoxidil and finasteride. Excessive hair growth is linked to certain disorders and can be managed with hormonal therapy and laser hair removal.

This article discusses androgenetic alopecia, including its prevalence, different patterns in men and women, and variations among races, without providing new clinical findings.

This chapter reviews low-level light therapy for hair growth and loss prevention but reports no new clinical results, providing an overview of mechanisms, treatments, and future perspectives.

This chapter reviews disorders of skin appendages including miliaria, acne, and alopecia, providing guidance on management and treatment but does not present new clinical findings.

This review discusses hormones that affect acne and highlights a statistically significant link between a low-glycemic-load diet and reduced acne activity, but reports no new experimental findings.

This chapter reviews various mucocutaneous manifestations of endocrine disorders and provides illustrative images of these clinical features, but reports no new research findings.

The document concludes that accurate diagnosis of male and female gonadal disorders is crucial for effective treatment and better patient outcomes.

This chapter reviews polycystic ovary syndrome (PCOS), focusing on its definition, causes, and treatment approaches, but reports no new research findings.

This chapter reviews classification and techniques of surgical therapies for treating stable, recalcitrant vitiligo, highlighting their role alongside non-surgical methods for small, specific cases.

This study observed that the use of hormonal hair products remains common among US Army School personnel, with higher use rates among non-white, female, and enlisted individuals.

This study reports a novel TRbeta gene mutation associated with resistance to thyroid hormone syndrome, which may contribute to various forms of alopecia in the affected family members.

This article explores the social and psychological factors driving male body hair grooming and the psychosocial effects of both hair removal and male pattern balding, without reporting new clinical findings.

This case report describes how a 23-year-old woman experienced eyebrow thinning and hair loss linked to cosmetic use, with diagnostic tests confirming follicular damage. Discontinuing the product led to eyebrow regrowth, highlighting potential risks from cosmetics and the value of non-invasive diagnostics for evaluation.

This study found that combining hysteroscopic surgery with Diane-35 significantly improved treatment efficacy and reduced the recurrence rate of endometrial polyps compared to hysteroscopy alone, while also resulting in lower endometrial thickness at 6-month and 12-month follow-ups.

This study found that long-term dutasteride therapy in men with benign prostatic hyperplasia worsened erectile dysfunction, reduced testosterone levels, and increased blood glucose and lipid profile, indicating negative metabolic impacts.